Synendos
Founded 2019 · 3 known investors
Synendos Therapeutics is a clinical-stage neuroscience company developing therapies that target the Endocannabinoid System to treat neuropsychiatric disorders at their root cause. Its focus is on anxiety- and mood-related conditions such as General Anxiety Disorder (GAD) and Post-Traumatic Stress Disorder (PTSD).
BiotechDeep TechMental Health
Investors · 3
In the news
Frequently asked questions
- What does Synendos do?
- Synendos Therapeutics is a clinical-stage neuroscience company developing therapies that target the Endocannabinoid System to treat neuropsychiatric disorders at their root cause. Its focus is on anxiety- and mood-related conditions such as General Anxiety Disorder (GAD) and Post-Traumatic Stress Disorder (PTSD).
- Who are Synendos's investors?
- Synendos's investors include Kurma Partners, Sunstone Capital, Ysios Capital.